JP2005518354A5 - - Google Patents

Download PDF

Info

Publication number
JP2005518354A5
JP2005518354A5 JP2003545335A JP2003545335A JP2005518354A5 JP 2005518354 A5 JP2005518354 A5 JP 2005518354A5 JP 2003545335 A JP2003545335 A JP 2003545335A JP 2003545335 A JP2003545335 A JP 2003545335A JP 2005518354 A5 JP2005518354 A5 JP 2005518354A5
Authority
JP
Japan
Prior art keywords
component
agents
pharmaceutical composition
codrug
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2003545335A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005518354A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/037035 external-priority patent/WO2003043657A1/en
Publication of JP2005518354A publication Critical patent/JP2005518354A/ja
Publication of JP2005518354A5 publication Critical patent/JP2005518354A5/ja
Abandoned legal-status Critical Current

Links

JP2003545335A 2001-11-19 2002-11-19 コドラッグを含有する医薬組成物 Abandoned JP2005518354A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33151201P 2001-11-19 2001-11-19
PCT/US2002/037035 WO2003043657A1 (en) 2001-11-19 2002-11-19 Topical delivery of codrugs

Publications (2)

Publication Number Publication Date
JP2005518354A JP2005518354A (ja) 2005-06-23
JP2005518354A5 true JP2005518354A5 (https=) 2006-01-19

Family

ID=23294274

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003545335A Abandoned JP2005518354A (ja) 2001-11-19 2002-11-19 コドラッグを含有する医薬組成物

Country Status (6)

Country Link
US (3) US20030118528A1 (https=)
EP (1) EP1448231A1 (https=)
JP (1) JP2005518354A (https=)
AU (1) AU2002350207A1 (https=)
CA (1) CA2467559A1 (https=)
WO (1) WO2003043657A1 (https=)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417227B1 (en) * 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
US20040022853A1 (en) * 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
NZ528994A (en) * 2001-04-26 2006-02-24 Control Delivery Sys Inc Sustained release drug delivery system containing codrugs
JP4814486B2 (ja) * 2001-06-05 2011-11-16 シヴィダ・インコーポレイテッド 持続放出性鎮痛性化合物
IN2014DN10834A (https=) * 2001-09-17 2015-09-04 Psivida Inc
AU2002350207A1 (en) * 2001-11-19 2003-06-10 Control Delivery Systems, Inc. Topical delivery of codrugs
EP1461122A4 (en) * 2001-12-10 2006-08-23 Control Delivery Sys Inc TREATMENT OF DISEASES OF THE UROGENITAL SYSTEM
US20040022815A1 (en) * 2002-08-05 2004-02-05 Orchid Health Care Novel pharmaceutical composition of ceftiofur
WO2005009480A2 (en) * 2003-06-11 2005-02-03 Control Delivery Systems, Inc. Implants containing codrugs
US8267914B1 (en) * 2003-10-16 2012-09-18 University Of Notre Dame Du Lac Method and apparatus for AC electrospray
US9248146B2 (en) * 2003-10-24 2016-02-02 Adhesives Research, Inc. Dissolvable adhesive films for delivery of pharmaceutical or cosmetic agents
WO2005039499A2 (en) 2003-10-24 2005-05-06 Adhesives Research, Inc. Rapidly disintegrating film
EP1744787A4 (en) * 2004-05-14 2011-04-06 Interface Biologics Inc POLYMER COUPLING AGENTS AND PHARMACEUTICALLY ACTIVE POLYMERS MANUFACTURED THEREOF
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
EP1812017A2 (en) * 2004-10-21 2007-08-01 Duke University Ophthamological drugs
US20060105941A1 (en) * 2004-11-12 2006-05-18 Allergan, Inc. Mixed antibiotic codrugs
US20060222692A1 (en) * 2005-03-31 2006-10-05 Fairfield Clinical Trials Llc Method and compositions for transdermal administration of antimicrobial medications
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
WO2008115590A1 (en) * 2007-03-21 2008-09-25 Alza Corporation Apparatus and method for transdermal delivery of a benzodiazepine
WO2008146224A2 (en) 2007-05-25 2008-12-04 Compex Medical S.A. Wound healing electrode set
WO2009143299A1 (en) 2008-05-20 2009-11-26 Neurogesx, Inc. Hepatoprotectant acetaminophen mutual prodrugs
WO2010022326A2 (en) * 2008-08-22 2010-02-25 Us Worldmeds Llc Transdermal delivery of apomorphine using microneedles
US20100086581A1 (en) * 2008-10-07 2010-04-08 Ernest Bove Method for purpura reduction and prevention
US11731991B2 (en) 2008-11-03 2023-08-22 Lehigh University Augmenting moieties for anti-inflammatory compounds
DE102009008256A1 (de) * 2009-02-10 2010-08-12 Lts Lohmann Therapie-Systeme Ag Prodrugs vom Typ N-hydroxylierter Amidine, Guanidine und/oder Aminohydrazone zur Applikation über die Haut
BRPI0900238A2 (pt) 2009-02-12 2010-10-26 Arch Chem Inc composição antimicrobiana e processo para controle da contaminação microbiana em processos de fermentação alcóolica
KR101751906B1 (ko) 2009-03-04 2017-06-29 엠플리큐어 아베 새로운 오용 방지 배합물
EP2427177B1 (en) 2009-05-08 2018-03-28 Emplicure AB Composition for sustained drug delivery comprising geopolymeric binder
JP5833007B2 (ja) 2009-08-31 2015-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ステロイドを含む局所製剤
US20160038600A1 (en) 2012-08-03 2016-02-11 Neonc Technologies Inc. Pharmaceutical compositions comprising poh derivatives
NO2613784T3 (https=) * 2010-09-07 2018-05-12
CN105616391B (zh) * 2010-12-17 2021-03-19 尼昂克技术公司 使用异紫苏醇的方法和装置
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
BR112015021388A2 (pt) 2013-03-08 2017-07-18 Allergan Inc conjugados esteroides de ciclosporina a
RU2015138891A (ru) 2013-03-08 2017-04-11 Аллерган, Инк. Конъюгаты антибиотиков, напрямую связанные со стероидными препаратами
US9512068B2 (en) 2013-03-15 2016-12-06 Rutgers, The State University Of New Jersey Augmenting moieties for anti-inflammatory compounds
AP2015008920A0 (en) 2013-06-04 2015-12-31 Lohmann Therapie Syst Lts Transdermal delivery system
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
IL255290B2 (en) 2015-04-27 2024-01-01 Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct Substances that bind to EGF1 and their use in the treatment of inflammatory diseases and tumors
BR112018000217A2 (pt) 2015-07-15 2018-09-04 Celator Pharmaceuticals Inc sistemas de distribuição de nanopartículas aperfeiçoados
US10286095B2 (en) 2015-09-11 2019-05-14 Olson Ip Technologies, Inc. Travel kit
KR20180058758A (ko) 2015-09-22 2018-06-01 그레이버그 비젼, 인크. 안구 장애의 치료를 위한 화합물 및 조성물
WO2017165502A1 (en) * 2016-03-22 2017-09-28 The General Hospital Corporation Compositions and methods for topical delivery of pharmaceutical agents
WO2018081389A1 (en) * 2016-10-26 2018-05-03 Georgia State University Research Foundation, Inc. Devices and methods for the treatment of a zoonotic herpesvirus infection
EP3600324A4 (en) 2017-03-23 2020-12-09 Graybug Vision, Inc. COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS
AU2018265415A1 (en) 2017-05-10 2019-10-31 Graybug Vision, Inc. Extended release microparticles and suspensions thereof for medical therapy
CN111971292B (zh) 2018-02-02 2024-12-13 波纹疗法公司 包含类固醇二聚体的玻璃制剂及其用途
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
EP3996764A4 (en) * 2019-07-10 2023-11-01 Ripple Therapeutics Corporation SURFACE COATINGS, IMPLANTABLE DEVICES COMPRISING DIMER STEROID PRODRUGS AND USES THEREOF
US12509469B2 (en) 2019-08-07 2025-12-30 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependence disorders
US11389409B2 (en) * 2019-08-30 2022-07-19 Remedy Diagnostics LLC Transdermal device comprising acetaminophen prodrug
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
CN113332588B (zh) * 2021-05-26 2023-05-09 四川大学 用于口腔黏膜给药的尖端载药可溶性微针贴片及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2999102A (en) * 1959-10-14 1961-09-05 Thomae Gmbh Dr K Bis-(steroid-21)-dicarboxylic acid esters
US3147183A (en) * 1962-04-16 1964-09-01 Boehringer Sohn Ingelheim Bis-(steroid-21)-dicarboxylic acid esters
FR2576213B1 (fr) * 1985-01-21 1989-02-24 Cortial Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee
US5028431A (en) * 1987-10-29 1991-07-02 Hercon Laboratories Corporation Article for the delivery to animal tissue of a pharmacologically active agent
TW225536B (https=) * 1990-08-23 1994-06-21 Ciba Geigy Ag
US5681964A (en) * 1990-10-23 1997-10-28 University Of Kentucky Research Foundation Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
CA2132342A1 (en) * 1992-04-06 1993-10-14 Kenneth F. Buechler Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
US6051576A (en) * 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
DE19607395C2 (de) * 1996-02-28 2002-11-21 Lohmann Therapie Syst Lts Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate
US6593292B1 (en) * 1999-08-24 2003-07-15 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
FR2803849B1 (fr) * 2000-01-19 2002-04-19 Centre Nat Rech Scient Molecules chimeres formees de psoralene et de retinoide, leur procede de preparation, et leurs applications au traitement de pathologies de l'hyperproliferation cellulaire et notamment du psoriasis
US6306842B1 (en) * 2000-06-02 2001-10-23 Medinox, Inc. Protected forms of a combination of pharmacologically active agents and uses therefor
AU2002350207A1 (en) * 2001-11-19 2003-06-10 Control Delivery Systems, Inc. Topical delivery of codrugs
WO2003061626A1 (en) * 2002-01-18 2003-07-31 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs

Similar Documents

Publication Publication Date Title
JP2005518354A5 (https=)
JP2005518354A (ja) コドラッグを含有する医薬組成物
JP5105697B2 (ja) コドラッグのコントロールデリバリ用ポリマー性ゲルシステム
JP5628467B2 (ja) 生体分解性徐放性ドラッグデリバリーシステム
US20040180036A1 (en) Salts of codrugs and uses related thereto
EP2123274B1 (en) Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
TW413637B (en) Preparation for percutaneous absorption
ES2549924T3 (es) Análogos de ácido araquidónico y métodos para tratamiento analgésico usando el mismo
PT1962817E (pt) Administração transdérmica de uma forma de sal de meptazinol
US20230128252A1 (en) Pharmaceutical compositions
WO1999059603A1 (en) Remedies for joint diseases bound to hyaluronic acid
JP2005513050A (ja) 尿生殖路疾患の治療
TW200526272A (en) Suspension delivery system for the sustained and controlled local release of pharmaceuticals
JP3187806B2 (ja) ニトロイミダゾール系化合物を含むアトピー性皮膚炎治療用の外用剤
JP6566707B2 (ja) 経皮唾液腺投与用の唾液分泌促進剤
JP3568881B2 (ja) 皮膚疾患治療用外用剤
ES2356563T3 (es) Administración transdérmica de meptazinol.
JP3538367B2 (ja) 皮膚組織障害治療・予防・改善用外用剤
Singh et al. Use of Nanotechnology in Pain Management
JP2001288082A (ja) 乾癬治療・予防用外用剤
HK1174895B (en) Arachidonic acid analogs and methods for analgesic treatment using same